BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21970911)

  • 41. [Locomotive syndrome and frailty. Osteoporosis as an underlying disorder in the locomotive syndrome].
    Hagino H
    Clin Calcium; 2012 Apr; 22(4):41-8. PubMed ID: 22460510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging drugs for osteoporosis.
    Feurer E; Chapurlat R
    Expert Opin Emerg Drugs; 2014 Sep; 19(3):385-95. PubMed ID: 24995794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention and management of osteoporotic fractures by non-physician health professionals: a systematic literature review to inform EULAR points to consider.
    Wilson N; Hurkmans E; Adams J; Bakkers M; Balážová P; Baxter M; Blavnsfeldt AB; Briot K; Chiari C; Cooper C; Dragoi R; Gäbler G; Lems W; Mosor E; Pais S; Simon C; Studenic P; Tilley S; de la Torre J; Stamm TA
    RMD Open; 2020 Jan; 6(1):. PubMed ID: 32144136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of osteobiologics in the management of osteoporotic fractures.
    Nauth A; Miclau T; Bhandari M; Schemitsch EH
    J Orthop Trauma; 2011 Jun; 25 Suppl 2():S51-5. PubMed ID: 21566475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two-year adherence to treatment and associated factors in a fracture liaison service in Spain.
    Naranjo A; Ojeda-Bruno S; Bilbao-Cantarero A; Quevedo-Abeledo JC; Diaz-González BV; Rodríguez-Lozano C
    Osteoporos Int; 2015 Nov; 26(11):2579-85. PubMed ID: 26048675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gaps and alternative surgical and non-surgical approaches in the bone fragility management: an updated review.
    Tarantino U; Cariati I; Greggi C; Iundusi R; Gasbarra E; Iolascon G; Kurth A; Akesson KE; Bouxsein M; Tranquilli Leali P; Civinini R; Falez F; Brandi ML
    Osteoporos Int; 2022 Dec; 33(12):2467-2478. PubMed ID: 35851407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adherence with medications used to treat osteoporosis: behavioral insights.
    Schousboe JT
    Curr Osteoporos Rep; 2013 Mar; 11(1):21-9. PubMed ID: 23334573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and forensic medicine issues in osteoporosis fractures.
    Molfetta L; Caldo D
    Aging Clin Exp Res; 2011 Apr; 23(2 Suppl):17-9. PubMed ID: 21970909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How can we influence the incidence of secondary fragility fractures? A review on current approaches.
    Pape HC; Bischoff-Ferrari HA
    Injury; 2017 Dec; 48 Suppl 7():S24-S26. PubMed ID: 28870622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using a sequential explanatory mixed method to evaluate the therapeutic window of opportunity for initiating osteoporosis treatment following fragility fractures.
    Roux S; Gaboury I; Gionet-Landry N; Garant MP; Beaulieu MC; Carrier N; Cabana F; Boire G
    Osteoporos Int; 2018 Apr; 29(4):961-971. PubMed ID: 29445831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hip Fracture--Epidemiology, Management and Liaison Service. Osteoporosis liaison service in Japan].
    Suzuki A; Sekiguchi-Ueda S; Kakita A
    Clin Calcium; 2015 Apr; 25(4):559-63. PubMed ID: 25814017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Secondary prevention program for osteoporotic fractures at Lille University Hospital.
    Abbad N; Lemeunier L; Chantelot C; Puisieux F; Cortet B
    Presse Med; 2016 Mar; 45(3):375-7. PubMed ID: 26826897
    [No Abstract]   [Full Text] [Related]  

  • 53. 2019 EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older.
    Adams J; Wilson N; Hurkmans E; Bakkers M; Balážová P; Baxter M; Blavnsfeldt AB; Briot K; Chiari C; Cooper C; Dragoi RG; Gäbler G; Lems W; Mosor E; Pais S; Simon C; Studenic P; Tilley S; de la Torre-Aboki J; Stamm TA
    Ann Rheum Dis; 2021 Jan; 80(1):57-64. PubMed ID: 32332077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Bone health in Geneva retirees].
    Biver E; Durosier C; Chevalley T; Rizzoli R; Ferrari S
    Rev Med Suisse; 2015 Mar; 11(466):638, 640-4. PubMed ID: 25962224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low prevalence of osteoporosis treatment in patients with recurrent major osteoporotic fracture.
    Flais J; Coiffier G; Le Noach J; Albert JD; Faccin M; Perdriger A; Thomazeau H; Guggenbuhl P
    Arch Osteoporos; 2017 Dec; 12(1):24. PubMed ID: 28251468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Secondary prevention after an osteoporosis-related fracture: an overview.
    Sale JE; Beaton D; Bogoch E
    Clin Geriatr Med; 2014 May; 30(2):317-32. PubMed ID: 24721371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgeons save bones: an algorithm for orthopedic surgeons managing secondary fracture prevention.
    Gosch M; Kammerlander C; Roth T; Doshi HK; Gasser RW; Blauth M
    Arch Orthop Trauma Surg; 2013 Aug; 133(8):1101-8. PubMed ID: 23681470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Osteoporosis.
    Ensrud KE; Crandall CJ
    Ann Intern Med; 2024 Jan; 177(1):ITC1-ITC16. PubMed ID: 38190715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Epidemiology of bone and joint disease - the present and future - . Risk and prevention/treatment of fractures associated with lifestyle-related diseases].
    Yamauchi M
    Clin Calcium; 2014 May; 24(5):733-42. PubMed ID: 24769685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patient-Related Factors Associated with Adherence to Recommendations Made by a Fracture Liaison Service: A Mixed-Method Prospective Study.
    Luc M; Corriveau H; Boire G; Filiatrault J; Beaulieu MC; Gaboury I
    Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29747415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.